Variation in neurophysiological function and evidence of quantitative electroencephalogram discordance: Predicting cocaine-dependent treatment attrition

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 18, Issue 2, 2006, Pages 208-216

  Venneman, Sandy ^a   Leuchter, Andrew ^b   Bartzokis, George ^b   Beckson, Mace ^b   Simon, Sara L ^b   Schaefer, Melodie ^b   Rawson, Richard ^b   Newton, Tom ^b   Cook, Ian A ^b   Uijtdehaage, Sebastian ^b   Ling, Walter ^b  

^a UNIVERSITY OF HOUSTON VICTORIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZOYLECGONINE; PLACEBO; SELEGILINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; ELECTROENCEPHALOGRAM; FEMALE; HIGH RISK POPULATION; HUMAN; MALE; NEUROPHYSIOLOGY; PRIORITY JOURNAL; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

EID: 33646725989     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.2006.18.2.208     Document Type: Article

References (39)

1. Feingold A, Oliveto A, Schottenfeld R, et al: Utility of crossover designs in clinical trials: efficacy of desipramine vs placebo in opioid-dependent cocaine abusers. Am J Addict 2002; 11:111-123
2. Batki SL, Washburn AM, Delucchi K, et al: A controlled trial of fluoxetine in crack cocaine dependence. Drug Alcohol Depend 1996; 41:137-142
3. Margolin A, Kosten TR, Avants SK, et al: A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients. Drug Alcohol Depend 1995; 40:125-131
4. Nunes EV, McGrath PJ, Quitkin FM, et al: Imipramine treatment of cocaine abuse: possible boundaries of efficacy. Drug Alcohol Depend 1995; 39:185-195
5. Brady KT, Sonne SC, Malcolm RJ, et al: Carbamazepine in the treatment of cocaine dependence: subtyping by affective disorder. Exp Clin Psychopharmacol 2002; 10:276-285
6. Gawin FH, Kleber HD, Byck R, et al: Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry 1989; 46:117-121
7. Crosby RD, Pearson VL, Eller C, et al: Phenytoin in the treatment of cocaine abuse: a double-blind study. Clin Pharmacol Ther 1996; 59:458-468
8. Handelsman L, Rosenblum A, Palij M, et al: Bromocriptine for cocaine dependences controlled clinical trial. Am J Addict 1997; 6:54-64
9. Levin FR, McDowell D, Evans SM, et al: Pergolide mesylate for cocaine abuse: a controlled preliminary trial. Am J Addict 1999; 8:120-127
10. Malcolm R, Kajdasz DK, Herron J, et al: A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence. Drug Alcohol Depend 2000; 60:161-168
11. Kolar AF, Brown BS, Weddington WW, et al: Treatment of cocaine dependence in methadone maintenance clients: a pilot study comparing the efficacy of desipramine and amantadine. Int J Addict 1992; 27:849-868
12. Schubiner H, Saules KK, Arfken CL, et al: Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol 2002; 10:286-294
13. Cornish JW, Maany I, Fudala PJ, et al: A randomized, double-blind, placebo-controlled study of ritanserin pharmacotherapy for cocaine dependence. Drug Alcohol Depend 2001; 61:183-189
14. Jenkins SW, Warfield NA, Blaine JD, et al: A pilot trial of gepirone vs placebo in the treatment of cocaine dependency. Psychopharmacol Bull 1992; 28:21-26
15. Rosse RB, Alim TN, Fay-McCarthy M, et al: Nimodipine pharmacotherapeutic adjuvant therapy for inpatient treatment of cocaine dependence. Clin Neuropharmacol 1994; 17:348-358
16. Oslin DW, Pettinati HM, Volpicelli JR, et al: The effects of naltrexone on alcohol and cocaine use in dually addicted patients. J Subst Abuse Treat 1999; 16:163-167
17. de Lima MS, de Oliveira Scares BG, Reisser AA, et al: Pharmacological treatment of cocaine dependence: a systematic review. Addiction 2002; 97:931-949
18. 2-weighted MR imaging signal abnormalities in the brain of cocaine-dependent patients is age-related and region-specific. Am J Neuroradiol 1999; 20:1628-1635
19. Smelson DA, Losonczy MF, Davis CW, et al: Kisperidone decreases craving and relapse in individuals with schizophrenia and cocaine dependence. Can J Psychiatry 2002; 47:671-675
20. Shaner A, Khalsa E, Roberts L, et al: Unrecognized cocaine use among schizophrenic patients. Am J Psychiatry 1993; 150(5):758-762
21. Nestler EJ: Cellular and molecular mechanisms of addiction, in Neurobiology of Mental Illness. Edited by Charney DS, Nestler EJ, Bunney BS. New York, Oxford University Press, 1999, pp. xix, 958
22. Newton TF, Cook IA, Kalechstein AD, et al: Qualitative EEG abnormalities in recently abstinent methamphetamine dependent individuals. Clin Neurophysiol 2003; 114:410-415
23. Kampman KM, Alterman AI, Volpicelli JR, et al: Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment. Psychol Addict Behav 2001; 15:52-59
24. Kampman KM, Volpicelli JR, Mulvaney F, et al: Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence. Addict Behav 2002; 27:251-260
25. Herning RI, Glover BJ, Koeppl B, et al: Cocaine-induced increases in EEG alpha and beta activity: Evidence for reduced cortical processing. Neuropsychopharmacology 1994; 11:1-9
26. Herning RI, King DE: EEG and evoked potentials alterations in cocaine-dependent individuals, in Neurotoxicity and Neuropathology Associated With Cocaine Abuse. National Institute on Drug Abuse Research Monograph Series, Monograph 163, Rockville, Md., National Institute on Drug Abuse, 1996
27. Leuchter AF, Cook IA, Dunkin JJ, et al: Cordance: a new method for assessment of cerebral perfusion and metabolism using quantitative electroencephalography. Neuroimage 1994; 1:208-219
28. Leuchter AF, Uijtdehaage SHJ, Cook IA, et al: Relationship between brain electrical activity and cortical perfusion in normal subjects. Psychiatry Res 1999; 90:125-140
29. Leuchter AF, Dunkin J, Lufkin R, Anzai Y, et al: Effect of white-matter disease on functional connections in the aging brain. J Neurol Neurosurg Psychiatry 1994; 57:1347-1354
30. Cook IA, O'Hara R, Uijtdehaage SHJ, et al: Assessing the accuracy of topographic EEG mapping for determining local brain function. Electroencephalogr Clin Neurophysiol 1998; 107:408-414
31. Hjorth B: An online transformation of EEG scalp potentials into orthogonal source derivations. Electroencephalogr Clin Neurophysiol 1975; 38:526-530
32. Leuchter AF, Cook IA, Mena I, et al: Assessing cerebral perfusion using quantitative EEG cordance. Psychiatry Research. Neuroimaging 1994; 55, 141-152
33. Leuchter AF, Daly KA, Rosenberg-Thompson S, et al: Prevalence and significance of electroencephalographic abnormalities in patients with suspected organic mental syndromes. J Am Geriatr Soc 1993; 41:605-611
34. Leuchter AF, Cook IA, Morgan ML, et al: Changes in brain function of depressed subjects during treatment with placebo. Am J Psychiatry 2002; 159:122-129
35. Cook IA, Leuchter AF, Morgan M, et al: Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology 2002; 27:120-131
36. Carroll KM, Nich C, Rounsaville BJ: Variability in treatment-seeking cocaine abusers: implications for clinical pharmacotherapy trials, in Medication Development for the Treatment of Cocaine Dependence: Issues in Clinical Efficacy Trials. Edited by B Tai, N Chiang, P Bridge. NIDA Research Monograph 175, U.S. Department of Health and Human Services, National Institutes of Health, 1997
37. Strickland TL, Mena I, Villanueva-Meyer J, et al: Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J Neuropsychiatry Clin Neurosci 1993; 5:419-427
38. Bartzokis G, Beckson M, Lu PH, et al: Brain maturation may be arrested in chronic cocaine addicts. Biol Psychiatry 2002; 51:605-612
39. Ling W, Shoptaw S, Wesson D, et al: Treatment effectiveness score as an outcome measure in clinical trials, in Medication Development for the Treatment of Cocaine Dependence: Issues in Clinical Efficacy Trials. Edited by B Tai, N Chiang, P Bridge. NIDA Research Monograph 175, U.S. Department of Health and Human Services, National Institutes of Health, 1997